vs

Side-by-side financial comparison of LANDS' END, INC. (LE) and NEOGEN CORP (NEOG). Click either name above to swap in a different company.

LANDS' END, INC. is the larger business by last-quarter revenue ($317.5M vs $224.7M, roughly 1.4× NEOGEN CORP). LANDS' END, INC. runs the higher net margin — 1.6% vs -7.1%, a 8.7% gap on every dollar of revenue. On growth, LANDS' END, INC. posted the faster year-over-year revenue change (0.1% vs -2.8%). NEOGEN CORP produced more free cash flow last quarter ($7.8M vs $-22.4M). Over the past eight quarters, NEOGEN CORP's revenue compounded faster (-0.9% CAGR vs -0.9%).

Lands' End, Inc. is an American retailer of clothing, baggage, and furniture which began as a mail-order yachting supply company in 1963 in Chicago. The company is named after Land's End; after promotional materials were printed, the founder noticed the typographical error in the location of the apostrophe, but could not afford to reprint the material. The company operates 26 domestic stores as of February 2024. Lands' End is headquartered in Dodgeville, Wisconsin.

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abuse...

LE vs NEOG — Head-to-Head

Bigger by revenue
LE
LE
1.4× larger
LE
$317.5M
$224.7M
NEOG
Growing faster (revenue YoY)
LE
LE
+2.9% gap
LE
0.1%
-2.8%
NEOG
Higher net margin
LE
LE
8.7% more per $
LE
1.6%
-7.1%
NEOG
More free cash flow
NEOG
NEOG
$30.2M more FCF
NEOG
$7.8M
$-22.4M
LE
Faster 2-yr revenue CAGR
NEOG
NEOG
Annualised
NEOG
-0.9%
-0.9%
LE

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
LE
LE
NEOG
NEOG
Revenue
$317.5M
$224.7M
Net Profit
$5.2M
$-15.9M
Gross Margin
51.8%
47.5%
Operating Margin
5.3%
-2.4%
Net Margin
1.6%
-7.1%
Revenue YoY
0.1%
-2.8%
Net Profit YoY
198.3%
96.5%
EPS (diluted)
$0.17
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LE
LE
NEOG
NEOG
Q4 25
$317.5M
$224.7M
Q3 25
$209.2M
Q2 25
$261.2M
$225.4M
Q1 25
$221.0M
Q4 24
$318.6M
$231.3M
Q3 24
$317.2M
$217.0M
Q2 24
$285.5M
$236.8M
Q1 24
$514.9M
$228.8M
Net Profit
LE
LE
NEOG
NEOG
Q4 25
$5.2M
$-15.9M
Q3 25
$36.3M
Q2 25
$-8.3M
$-612.3M
Q1 25
$-10.9M
Q4 24
$-593.0K
$-456.3M
Q3 24
$-5.3M
$-12.6M
Q2 24
$-6.4M
$-5.4M
Q1 24
$-8.6M
$-2.0M
Gross Margin
LE
LE
NEOG
NEOG
Q4 25
51.8%
47.5%
Q3 25
45.4%
Q2 25
50.8%
41.2%
Q1 25
49.9%
Q4 24
50.6%
49.0%
Q3 24
47.9%
48.4%
Q2 24
48.7%
47.9%
Q1 24
38.0%
51.1%
Operating Margin
LE
LE
NEOG
NEOG
Q4 25
5.3%
-2.4%
Q3 25
-7.7%
Q2 25
-0.9%
-271.1%
Q1 25
2.4%
Q4 24
2.9%
-197.8%
Q3 24
0.8%
1.0%
Q2 24
0.8%
5.5%
Q1 24
1.6%
5.3%
Net Margin
LE
LE
NEOG
NEOG
Q4 25
1.6%
-7.1%
Q3 25
17.4%
Q2 25
-3.2%
-271.6%
Q1 25
-4.9%
Q4 24
-0.2%
-197.3%
Q3 24
-1.7%
-5.8%
Q2 24
-2.3%
-2.3%
Q1 24
-1.7%
-0.9%
EPS (diluted)
LE
LE
NEOG
NEOG
Q4 25
$0.17
$-0.07
Q3 25
$0.17
Q2 25
$-0.27
$-2.82
Q1 25
$-0.05
Q4 24
$-0.02
$-2.10
Q3 24
$-0.17
$-0.06
Q2 24
$-0.20
$-0.02
Q1 24
$-0.27
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LE
LE
NEOG
NEOG
Cash + ST InvestmentsLiquidity on hand
$36.3M
$145.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$231.0M
$2.1B
Total Assets
$852.7M
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LE
LE
NEOG
NEOG
Q4 25
$36.3M
$145.3M
Q3 25
$138.9M
Q2 25
$18.1M
$129.0M
Q1 25
$127.7M
Q4 24
$30.4M
$140.2M
Q3 24
$25.6M
$120.5M
Q2 24
$27.4M
$170.9M
Q1 24
$25.3M
$168.4M
Stockholders' Equity
LE
LE
NEOG
NEOG
Q4 25
$231.0M
$2.1B
Q3 25
$2.1B
Q2 25
$230.1M
$2.1B
Q1 25
$2.7B
Q4 24
$223.6M
$2.7B
Q3 24
$226.5M
$3.1B
Q2 24
$234.6M
$3.1B
Q1 24
$241.6M
$3.1B
Total Assets
LE
LE
NEOG
NEOG
Q4 25
$852.7M
$3.4B
Q3 25
$3.4B
Q2 25
$760.5M
$3.4B
Q1 25
$4.0B
Q4 24
$843.6M
$4.1B
Q3 24
$802.5M
$4.5B
Q2 24
$800.1M
$4.5B
Q1 24
$811.5M
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LE
LE
NEOG
NEOG
Operating Cash FlowLast quarter
$-15.7M
$19.4M
Free Cash FlowOCF − Capex
$-22.4M
$7.8M
FCF MarginFCF / Revenue
-7.1%
3.5%
Capex IntensityCapex / Revenue
2.1%
5.2%
Cash ConversionOCF / Net Profit
-3.03×
TTM Free Cash FlowTrailing 4 quarters
$-55.0M
$-18.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LE
LE
NEOG
NEOG
Q4 25
$-15.7M
$19.4M
Q3 25
$10.9M
Q2 25
$-22.5M
$16.4M
Q1 25
$19.5M
Q4 24
$-17.1M
$40.3M
Q3 24
$30.7M
$-17.9M
Q2 24
$-25.8M
$26.7M
Q1 24
$93.9M
$-30.2M
Free Cash Flow
LE
LE
NEOG
NEOG
Q4 25
$-22.4M
$7.8M
Q3 25
$-13.1M
Q2 25
$-30.7M
$349.0K
Q1 25
$-13.4M
Q4 24
$-27.8M
$23.1M
Q3 24
$26.0M
$-56.3M
Q2 24
$-32.6M
$2.5M
Q1 24
$87.5M
$-62.3M
FCF Margin
LE
LE
NEOG
NEOG
Q4 25
-7.1%
3.5%
Q3 25
-6.3%
Q2 25
-11.8%
0.2%
Q1 25
-6.1%
Q4 24
-8.7%
10.0%
Q3 24
8.2%
-26.0%
Q2 24
-11.4%
1.1%
Q1 24
17.0%
-27.2%
Capex Intensity
LE
LE
NEOG
NEOG
Q4 25
2.1%
5.2%
Q3 25
11.5%
Q2 25
3.2%
7.1%
Q1 25
14.9%
Q4 24
3.3%
7.4%
Q3 24
1.5%
17.7%
Q2 24
2.4%
10.2%
Q1 24
1.2%
14.0%
Cash Conversion
LE
LE
NEOG
NEOG
Q4 25
-3.03×
Q3 25
0.30×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LE
LE

U Se Commerce$179.8M57%
Business Outfitters Revenue$78.8M25%
Licensing And Retail$20.2M6%
Other$19.8M6%
Third Party$18.9M6%

NEOG
NEOG

Other$109.2M49%
Bacterial And General Sanitation$44.9M20%
Services$25.7M11%
Natural Toxins And Allergens$20.4M9%
Animal Care$8.9M4%
Genomics Services$6.3M3%
Biosecurity Products$4.6M2%
Life Sciences$1.4M1%

Related Comparisons